Acute lymphoblastic leukemia. Acute lymphoblastic leukemia [ALL]
Conditions
Interventions
Intervention 1: Intervention Group 1: For eight weeks, the parent and the adolescent will receive a combined virtual intervention, including web application-based psychosocial skills training and peer
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to No maximum
Inclusion criteria
Inclusion criteria: Adolescents should be between the ages of 10-19 years. Adolescents must be diagnosed with Acute Lymphoblastic Leukemia (ALL) and currently undergoing treatment for leukemia in healthcare centers. Both adolescents and their families must express willingness to participate in quantitative and qualitative evaluations. Adolescents should have access to a smartphone and the internet. Adolescents must not have a physician-diagnosed mental illness (as reported by the individual or their family). Adolescents should not have received mental health interventions in the past six months. The parent must be the patient's primary caregiver. The adolescent and the parent must have basic literacy skills (reading and writing). The parent must not have a physician-diagnosed mental illness (as reported by the individual). The parent must have access to the internet and a smartphone. Individuals with key information and the ability to provide valuable insights (in both adolescent and parent groups).
Exclusion criteria
Exclusion criteria: Participants who express unwillingness to continue participation at any stage of the study. Individuals who are unable or unwilling to follow the study protocol, such as failing to complete questionnaires or not attending interview sessions. If the participant's physical or mental health status significantly changes, such as a worsening of the disease, diagnosis of a new illness, or the onset of severe anxiety symptoms requiring immediate intervention and treatment. Participants who are unable to use the program due to technical issues (such as lack of internet access, technical problems with software, or access to WhatsApp). Use of antidepressant or sedative medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: **Before and immediately after the intervention**. Method of measurement: Beck Anxiety Inventory (BAI).;Resilience. Timepoint: **Before and immediately after the intervention**. Method of measurement: Connor-Davidson Resilience Scale (CD-RISC). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehrvash Hemati
Shiraz University of Medical Sciences
Outcome results
None listed